Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia (Q46801696)

25 December 2017

title

Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia (English)

1 reference

25 December 2017

author name string

Joshua L Deignan

1

1 reference

25 December 2017

Bart Marescau

2

1 reference

25 December 2017

Justin C Livesay

3

1 reference

25 December 2017

Ramaswamy K Iyer

4

1 reference

25 December 2017

Peter P De Deyn

5

1 reference

25 December 2017

Stephen D Cederbaum

6

1 reference

25 December 2017

Wayne W Grody

7

1 reference

25 December 2017

publication date

7 November 2007

1 reference

25 December 2017

Molecular Genetics and Metabolism

published in

1 reference

25 December 2017

volume

93

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

172-178

1 reference

25 December 2017

Expression of arginase isozymes in mouse brain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Widespread expression of arginase I in mouse tissues. Biochemical and physiological implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Cloning and characterization of the human type II arginase gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Hyperargininemia with Arginase Deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Arginase deficiency manifesting delayed clinical sequelae and induction of a kidney arginase isozyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Arginases I and II: do their functions overlap?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Mouse model for human arginase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Ornithine deficiency in the arginase double knockout mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Guanidino compounds in plasma, urine and cerebrospinal fluid of hyperargininemic patients during therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Guanidino compounds in hyperargininemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Guanidino Compound Analysis as a Complementary Diagnostic Parameter for Hyperargininemia: Follow-Up of Guanidino Compound Levels during Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Guanidino compounds in uraemic dialysed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Effects of α-keto-δ-guanidinovaleric acid on inhibitory amino acid responses on mouse neurons in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Guanidino compounds that are increased in hyperargininemia inhibit GABA and glycine responses on mouse neurons in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

In vitro effects of L-arginine and guanidino compounds on NTPDase1 and 5'-nucleotidase activities from rat brain synaptosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

In vitro inhibition of Na+,K(+)-ATPase activity from rat cerebral cortex by guanidino compounds accumulating in hyperargininemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

In vitro stimulation of oxidative stress in cerebral cortex of rats by the guanidino compounds accumulating in hyperargininemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

The pathobiochemistry of uremia and hyperargininemia further demonstrates a metabolic relationship between urea and guanidinosuccinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Guanidino compounds in serum and urine of cirrhotic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Intrastriatal administration of guanidinoacetate inhibits Na+, K+-ATPase and creatine kinase activities in rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Glial and neuronal Na+-K+ pump in epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Alternative pathway therapy for urea cycle disorders: twenty years later

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Argininemia treated from birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

Treatment of hyperargininaemia due to arginase deficiency with a chemically defined diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.09.016

10.1016/J.YMGME.2007.09.016

7 January 2021

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

17997338

1 reference

25 December 2017